Pfizer (NYSE:PFE) Shares Down 1.5% - Should You Sell?
Market Beat·
- Pfizer shares fell 1.5% to $27.83 amid market developments, including litigation settlements and a race between new product pipelines and patent expirations.
- The company reported second-quarter earnings of $0.77 per share on revenue of $15.03 billion, outperforming Wall Street consensus estimates.
- Major institutional investors like Vanguard and BlackRock adjusted their stakes, while analysts maintained a consensus Hold rating with a target price of $28.28.